1.2190
+0.1190
+(10.82%)
As of 2:31:43 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,581,900 | 6 |
| Sales | 25,352 | 1 |
| Net Shares Purchased (Sold) | 1,556,548 | 7 |
| Total Insider Shares Held | 19.96M | -- |
| % Net Shares Purchased (Sold) | 8.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GRAHAM PETER J Officer | Stock Award(Grant) at price 1.61 per share. | Direct | 354,200 | Feb 13, 2025 |
| CARMONA JOSE Chief Financial Officer | Stock Award(Grant) at price 1.61 per share. | Direct | 386,400 | Feb 13, 2025 |
| MALLIK AMEET Chief Executive Officer | Stock Award(Grant) at price 1.61 per share. | Direct | 1,046,500 | Feb 13, 2025 |
| ZAKI MOHAMED Officer | Stock Award(Grant) at price 1.61 per share. | Direct | 370,300 | Feb 13, 2025 |
| KALLEBO LISA MICHELLE Officer | Stock Award(Grant) at price 1.61 per share. | Direct | 67,459 | Feb 13, 2025 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.22 - 2.28 per share. | Indirect | 450,000 | Dec 11, 2024 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.07 per share. | Indirect | 52,479 | Dec 4, 2024 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.68 per share. | Indirect | 2,944,000 | Jul 1, 2024 |
| SQUARER RON R Director | Sale at price 2.89 per share. | Direct | 20,216 | Jun 17, 2024 |
| BIZZARI JEAN-PIERRE Director | Sale at price 2.89 per share. | Direct | 20,216 | Jun 17, 2024 |
| SANDOR VICTOR Director | Sale at price 2.89 per share. | Direct | 20,216 | Jun 17, 2024 |
| AZELBY ROBERT W Director | Sale at price 2.89 per share. | Direct | 20,216 | Jun 17, 2024 |
| MONGES VIVIANE Director | Sale at price 2.89 per share. | Direct | 4,153 | Jun 17, 2024 |
| PFISTERER THOMAS Director | Sale at price 2.89 per share. | Direct | 4,153 | Jun 17, 2024 |
| HUG PETER Director | Sale at price 2.89 per share. | Direct | 3,448 | Jun 17, 2024 |
| SQUARER RON R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| BIZZARI JEAN-PIERRE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| SANDOR VICTOR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| AZELBY ROBERT W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| MONGES VIVIANE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| PFISTERER THOMAS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| HUG PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
| MALLIK AMEET Chief Executive Officer | Sale at price 4.48 per share. | Direct | 133,195 | May 7, 2024 |
Related Tickers
KURA Kura Oncology, Inc.
6.08
+8.10%
PASG Passage Bio, Inc.
0.3898
+19.57%
SNDX Syndax Pharmaceuticals, Inc.
11.65
+10.32%
ALEC Alector, Inc.
1.0300
+9.31%
AUTL Autolus Therapeutics plc
1.2250
+3.81%
FDMT 4D Molecular Therapeutics, Inc.
2.8800
+14.74%
ENTA Enanta Pharmaceuticals, Inc.
4.6300
+3.81%
SYRE Spyre Therapeutics, Inc.
13.57
+15.00%
SLN Silence Therapeutics plc
2.5250
+9.80%
CGEM Cullinan Therapeutics, Inc.
7.99
+9.15%